KC’s LifeCell promotes long-serving executive to president
This article was originally published in Clinica
Lisa Colleran has been named as the president of LifeCell (Branchburg, New Jersey), a firm that makes tissue-based products for use in reconstructive, orthopaedic and urogynaecologic surgical procedures. The firm is a subsidiary of Kinetic Concepts (San Antonio, Texas). Ms Colleran, who has been with the firm since 2002, has also been named as a member of Kinetic Concept’s executive committee. Previously, Ms Colleran was senior vice-president of LifeCell’s commercial operations. Prior to joining LifeCell, she served at Baxter Healthcare for 20 years. She replaces Paul Thomas, who has resigned.
You may also be interested in...
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.